<?xml version="1.0" encoding="UTF-8" standalone="no" ?>
<rss version="2.0">
  <channel>
    <title>Joosten, M.</title>
    <link>http://repub.eur.nl/res/aut/5209/</link>
    <description>List of Publications</description>
    <language>en</language>
    <image>
      <url>http://repub.eur.nl/static-eur/img/logo.png</url>
      <title>RePub, Erasmus University Rotterdam</title>
      <link>http://repub.eur.nl</link>
    </image>
    <item>
      <title>Translational control of putative protooncogene Nm23-M2 by cytokines via phosphoinositide 3-kinase signaling. (Article)</title>
      <link>http://repub.eur.nl/res/pub/13449/</link>
      <pubDate>2004-09-10T00:00:00Z</pubDate>
      <description>The expansion and differentiation of hematopoietic progenitors is
      regulated by cytokine and growth factor signaling. To examine how signal
      transduction controls the gene expression program required for progenitor
      expansion, we screened ATLAS filters with polysome-associated mRNA derived
      from erythroid progenitors stimulated with erythropoietin and/or stem cell
      factor. The putative proto-oncogene nucleoside diphosphate kinase B
      (ndpk-B or nm23-M2) was identified as an erythropoietin and stem cell
      factor target gene. Factor-induced expression of nm23-M2 was regulated
      specifically at the level of polysome association by a phosphoinositide
      3-kinase-dependent mechanism. Identification of the transcription
      initiation site revealed that nm23-M2 mRNA starts with a terminal
      oligopyrimidine sequence, which is known to render mRNA translation
      dependent on mitogenic factors. Recently, the nm23-M2 locus was identified
      as a common leukemia retrovirus integration site, suggesting that it plays
      a role in leukemia development. The expression of Nm23 from a retroviral
      vector in the absence of its 5'-untranslated region caused constitutive
      polysome association of nm23-M2. Polysome-association and protein
      expression of endogenous nm23-M2 declined during differentiation of
      erythroid progenitors, suggesting a role for Nm23-M2 in progenitor
      expansion. Taken together, nm23-m2 exemplifies that cytokine-dependent
      control of translation initiation is an important mechanism of gene
      expression regulation.</description>
    </item> <item>
      <title>Retroviral insertions in Evi12, a novel common virus integration site upstream of Tra1/Grp94, frequently coincide with insertions in the gene encoding the peripheral cannabinoid receptor Cnr2 (Article)</title>
      <link>http://repub.eur.nl/res/pub/9072/</link>
      <pubDate>1999-01-01T00:00:00Z</pubDate>
      <description>The common virus integration site (VIS) Evi11 was recently identified
      within the gene encoding the hematopoietic G-protein-coupled peripheral
      cannabinoid receptor Cnr2 (also referred to as Cb2). Here we show that
      Cnr2 is a frequent target (12%) for insertion of Cas-Br-M murine leukemia
      virus (MuLV) in primary tumors in NIH/Swiss mice. Multiple provirus
      insertions in Evi11 were cloned and shown to be located within the 3'
      untranslated region of the candidate proto-oncogene Cnr2. These results
      suggest that proviral insertion in the Cnr2 gene is an important step in
      Cas-Br-M MuLV-induced leukemogenesis in NIH/Swiss mice. To isolate
      Evi11/Cnr2 collaborating proto-oncogenes, we searched for novel common
      VISs in the Cas-Br-M MuLV-induced primary tumors and identified a novel
      frequent common VIS, Evi12 (14%). Interestingly, 54% of the
      Evi11/Cnr2-rearranged primary tumors contained insertions in Evi12 as
      well, which suggests cooperative action of the target genes in these two
      common VISs in leukemogenesis. By interspecific backcross analysis it was
      shown that Evi12 resides on mouse chromosome 10 in a region that shares
      homology with human chromosomes 12q and 19p. Sequence analysis
      demonstrated that Evi12 is located upstream of the gene encoding the
      molecular chaperone Tra1/Grp94, which was previously mapped to mouse
      chromosome 10 and human chromosome 12q22-24. Thus, Tra1/Grp94 is a
      candidate target gene for retroviral activation or inactivation in Evi12.
      However, Northern and Western blot analyses did not provide evidence that
      proviral insertion had altered the expression of Tra1/Grp94. Additional
      studies are required to determine whether Tra1/Grp94 or another candidate
      proto-oncogene in Evi12 is involved in leukemogenesis.</description>
    </item> <item>
      <title>A rapid RT-PCR based method to isolate complementary DNA fragments flanking retrovirus integration sites (Article)</title>
      <link>http://repub.eur.nl/res/pub/8724/</link>
      <pubDate>1997-01-01T00:00:00Z</pubDate>
      <description>Proto-oncogenes in retrovirally induced myeloid mouse leukemias are
          frequently activated following retroviral insertion. The identification of
          common virus integration sites (VISs) and isolation of the transforming
          oncogene is laborious and time consuming. We established a rapid and
          simple PCR based procedure which facilitates the identification of VISs
          and novel proto-oncogenes. Complementary DNA fragments adjacent to
          retrovirus integration sites were selectively isolated by applying a
          reverse transcriptase (RT) reaction using an oligo(dT)-adaptor primer,
          followed by PCR using the adaptor sequence and a retrovirus long terminal
          repeat (LTR) specific primer. Multiple chimeric cDNA fragments suitable
          for Southern and northern blot analysis were isolated.</description>
    </item>
  </channel>
</rss>